about
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentIL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.Treatment of chondral defects of the knee with one step matrix-assisted technique enhanced by autologous concentrated bone marrow: in vitro characterisation of mesenchymal stem cells from iliac crest and subchondral bone.Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells.Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerPatient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cellsMicroenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines.Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.In vivo Cancer Imaging with Semiconductor Quantum Dots
P50
Q24656967-C7536401-70B0-44F5-906B-6C3846D03C53Q33479161-23355F13-819E-4C1F-BD4A-0C89CB3EAEA6Q34142663-4148E456-BE5E-4EFD-8BDC-9E5B9C6BE8AAQ35060289-99702D54-78C7-4290-8A72-FCA23884ABB5Q35744111-A756C92F-6AC7-46F7-A607-2747A2A20149Q35884941-247188C4-2996-4BBB-8701-5479938C4607Q36935205-06ABE313-2A4C-4C91-AE08-78CACAB40BECQ38739226-93BB2192-251E-4216-81FC-1D172D5B656EQ38823872-28AE3BCB-876B-41B9-B019-B10D5E2790F5Q38856807-AD018AF3-DE87-48C7-B1C0-C55A35DD54E9Q39708447-E21B0107-F298-4D42-9B36-EA6BC5244443Q40423134-970A3463-D542-44FE-9B84-00BFE4BEAFEAQ59287232-9BEE5AB1-FB4C-4CE3-B886-037DC7100D72
P50
description
researcher, ORCID id # 0000-0002-8495-4594
@en
wetenschapper
@nl
name
Giulia Bertolini
@ast
Giulia Bertolini
@en
Giulia Bertolini
@es
Giulia Bertolini
@nl
type
label
Giulia Bertolini
@ast
Giulia Bertolini
@en
Giulia Bertolini
@es
Giulia Bertolini
@nl
prefLabel
Giulia Bertolini
@ast
Giulia Bertolini
@en
Giulia Bertolini
@es
Giulia Bertolini
@nl
P106
P1153
26532426700
P21
P31
P496
0000-0002-8495-4594